Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Dec;68(6):1097–1103. doi: 10.1038/bjc.1993.487

Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry.

S Schultz-Hector 1, A C Begg 1, I Hofland 1, J Kummermehr 1, M Sund 1
PMCID: PMC1968642  PMID: 8260360

Abstract

The study was originally set up to measure accurate cell kinetic parameters in two murine squamous cell carcinomas (scc) for comparison with radiobiological data on proliferation during radiotherapy. The tumours, AT84 and AT478, were both moderately well differentiated aneuploid scc. In the course of the study, several comparisons of techniques were made in two different centres. This paper reports on the results of those comparisons involving two different detection methods (flow cytometry and immunohistochemistry), single vs double labelling, and in vivo and in vitro labelling, the latter using tissue slices incubated under high pressure oxygen. Pulse labelling studies with bromodeoxyuridine (BrdUrd) showed that the labelling indices (LI) were not significantly different after in vitro or in vivo labelling. In addition, the flow cytometry (FCM) and immunohistochemistry (IHC) methods also gave labelling indices which were not significantly different. Only tumour cells were analysed in these studies by selecting cells on the basis of aneuploidy (FCM) or morphology (IHC). The DNA synthesis time of the tumour cells were analysed by both techniques. For FCM, the Relative Movement method was used (Begg et al., 1985). For IHC, a double labelling method was used, employing BrdUrd and triated thymidine (3H-TdR) administered several hours apart, detected simultaneously using immunoperoxidase and autoradiography, respectively. When both labels were administered in vivo, there was good agreement for Ts between the FCM and IHC methods. Attempts were also made to measure Ts in vitro using both techniques. With double labelling, it was found that cells did not take up the second label, implying a failure of cycle progression. This was confirmed by FCM results, showing no movement of labelled cells through the S-phase, despite an initially high uptake. This could not be influenced by lowering the DNA precursor concentration or by adding foetal calf serum. This indicates that DNA synthesis times are difficult or impossible to measure in vitro in fresh tumour explants. Finally, the double labelling IHC method allowed intratumoural variations of both LI and Ts to be studied. Both parameters were found to vary markedly throughout the tumour volume, particularly for larger tumours (600 mg), giving calculated local potential doubling time values (Tpot) ranging from 1-7 days.

Full text

PDF
1097

Images in this article

1100Figure 3
on p.1100

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakker P. J., Aten J. A., Tukker C. J., Barendsen G. W., Veenhof C. H. Flow cytometric analysis of experimental parameters for the immunofluorescent labeling of BrdUrd in various tumour cell lines. Histochemistry. 1989;91(5):425–429. doi: 10.1007/BF00493830. [DOI] [PubMed] [Google Scholar]
  2. Begg A. C., Hofland I. Cell kinetic analysis of mixed populations using three-color fluorescence flow cytometry. Cytometry. 1991;12(5):445–454. doi: 10.1002/cyto.990120510. [DOI] [PubMed] [Google Scholar]
  3. Begg A. C., McNally N. J., Shrieve D. C., Kärcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry. 1985 Nov;6(6):620–626. doi: 10.1002/cyto.990060618. [DOI] [PubMed] [Google Scholar]
  4. Begg A. C., Moonen L., Hofland I., Dessing M., Bartelink H. Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations. Radiother Oncol. 1988 Apr;11(4):337–347. doi: 10.1016/0167-8140(88)90205-8. [DOI] [PubMed] [Google Scholar]
  5. Begg AC. Critical Appraisal of In Situ Cell Kinetic Measurements as Response Predictors in Human Tumors. Semin Radiat Oncol. 1993 Apr;3(2):144–151. doi: 10.1054/SRAO00300144. [DOI] [PubMed] [Google Scholar]
  6. Bennett M. H., Wilson G. D., Dische S., Saunders M. I., Martindale C. A., Robinson B. M., O'Halloran A. E., Leslie M. D., Laing J. H. Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer. 1992 Jun;65(6):870–878. doi: 10.1038/bjc.1992.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Born R., Hug O., Trott K. R. The effect of prolonged hypoxia on growth and viability of Chinese hamster cells. Int J Radiat Oncol Biol Phys. 1976 Jul-Aug;1(7-8):687–697. doi: 10.1016/0360-3016(76)90151-6. [DOI] [PubMed] [Google Scholar]
  8. Böswald M., Harasim S., Maurer-Schultze B. Tracer dose and availability time of thymidine and bromodeoxyuridine: application of bromodeoxyuridine in cell kinetic studies. Cell Tissue Kinet. 1990 May;23(3):169–181. doi: 10.1111/j.1365-2184.1990.tb01113.x. [DOI] [PubMed] [Google Scholar]
  9. Carlton J. C., Terry N. H., White R. A. Measuring potential doubling times of murine tumors using flow cytometry. Cytometry. 1991;12(7):645–650. doi: 10.1002/cyto.990120709. [DOI] [PubMed] [Google Scholar]
  10. Chavaudra N., Richard J. M., Malaise E. P. Labelling index of human squamous cell carcinomas. Comparison of in vivo and in vitro labelling methods. Cell Tissue Kinet. 1979 Mar;12(2):145–152. doi: 10.1111/j.1365-2184.1979.tb00121.x. [DOI] [PubMed] [Google Scholar]
  11. Denekamp J., Kallman R. F. In vitro and in vivo labelling of animal tumours with tritiated thymidine. Cell Tissue Kinet. 1973 May;6(3):217–227. doi: 10.1111/j.1365-2184.1973.tb01611.x. [DOI] [PubMed] [Google Scholar]
  12. Denekamp J. The cellular proliferation kinetics of animal tumors. Cancer Res. 1970 Feb;30(2):393–400. [PubMed] [Google Scholar]
  13. Gasinska A., Wilson G. D., Urbanski K. Labelling index of gynaecological tumours assessed by bromodeoxyuridine staining in vitro using flow cytometry and histochemistry. Int J Radiat Biol. 1989 Nov;56(5):793–796. doi: 10.1080/09553008914552061. [DOI] [PubMed] [Google Scholar]
  14. Hoshino T., Nagashima T., Cho K. G., Murovic J. A., Hodes J. E., Wilson C. B., Edwards M. S., Pitts L. H. S-phase fraction of human brain tumors in situ measured by uptake of bromodeoxyuridine. Int J Cancer. 1986 Sep 15;38(3):369–374. doi: 10.1002/ijc.2910380311. [DOI] [PubMed] [Google Scholar]
  15. Hume W. J., Thompson J. Double labelling of tissue combining tritiated thymidine autoradiography with immunodetection of bromodeoxyuridine: the autoradiographic significance of inhibition of thymidine incorporation into DNA by bromodeoxyuridine given simultaneously. Cell Tissue Kinet. 1989 Sep;22(5):393–399. doi: 10.1111/j.1365-2184.1989.tb00224.x. [DOI] [PubMed] [Google Scholar]
  16. Knapp P. E. The cell cycle of glial cells grown in vitro: an immunocytochemical method of analysis. J Histochem Cytochem. 1992 Sep;40(9):1405–1411. doi: 10.1177/40.9.1506676. [DOI] [PubMed] [Google Scholar]
  17. Knapp P. E. The cell cycle of glial cells grown in vitro: an immunocytochemical method of analysis. J Histochem Cytochem. 1992 Sep;40(9):1405–1411. doi: 10.1177/40.9.1506676. [DOI] [PubMed] [Google Scholar]
  18. Meyer J. S., Nauert J., Koehm S., Hughes J. Cell kinetics of human tumors by in vitro bromodeoxyuridine labeling. J Histochem Cytochem. 1989 Sep;37(9):1449–1454. doi: 10.1177/37.9.2768814. [DOI] [PubMed] [Google Scholar]
  19. Meyer J. S., Prey M. U., Babcock D. S., McDivitt R. W. Breast carcinoma cell kinetics, morphology, stage, and host characteristics. A thymidine labeling study. Lab Invest. 1986 Jan;54(1):41–51. [PubMed] [Google Scholar]
  20. Meyer J. S., Prey M. U., Babcock D. S., McDivitt R. W. Breast carcinoma cell kinetics, morphology, stage, and host characteristics. A thymidine labeling study. Lab Invest. 1986 Jan;54(1):41–51. [PubMed] [Google Scholar]
  21. Meyer JS, He W. Cell Proliferation Measurements by Bromodeoxyuridine or Thymidine Incorporation: Clinical Correlates. Semin Radiat Oncol. 1993 Apr;3(2):126–134. doi: 10.1054/SRAO00300126. [DOI] [PubMed] [Google Scholar]
  22. Parkins C. S., Bush C., Price P., Steel G. G. Cell proliferation in human tumour xenografts: measurement using antibody labelling against bromodeoxyuridine and Ki-67. Cell Prolif. 1991 Mar;24(2):171–179. doi: 10.1111/j.1365-2184.1991.tb01147.x. [DOI] [PubMed] [Google Scholar]
  23. Preisler H. D., Gopal V., Banavali S. D., Finke D., Bokari S. A. Multiparameter assessment of the cell cycle effects of bioactive and cytotoxic agents. Cancer Res. 1992 Aug 1;52(15):4090–4095. [PubMed] [Google Scholar]
  24. Ramaekers F. C., Beck H. L., Feitz W. F., Oud P. S., Debruyne F. M., Vooijs G. P., Herman C. J. Application of antibodies to intermediate filament proteins as tissue-specific probes in the flow cytometric analysis of complex tumors. Anal Quant Cytol Histol. 1986 Dec;8(4):271–280. [PubMed] [Google Scholar]
  25. Raza A., Maheshwari Y., Yasin Z., Mandava N., Mayers G., Preisler H. D. A new method for studying cell cycle characteristics in ANLL using double-labeling with BrdU and 3HTdr. Leuk Res. 1987;11(12):1079–1087. doi: 10.1016/0145-2126(87)90160-3. [DOI] [PubMed] [Google Scholar]
  26. Schultz-Hector S., Haghayegh S. Beta-fibroblast growth factor expression in human and murine squamous cell carcinomas and its relationship to regional endothelial cell proliferation. Cancer Res. 1993 Mar 15;53(6):1444–1449. [PubMed] [Google Scholar]
  27. Schultze B., Maurer W., Hagenbusch H. A two emulsion autoradiographic technique and the discrimination of the three different types of labelling after double labelling with 3H- and 14C-thymidine. Cell Tissue Kinet. 1976 May;9(3):245–255. doi: 10.1111/j.1365-2184.1976.tb01272.x. [DOI] [PubMed] [Google Scholar]
  28. Shibui S., Hoshino T., Vanderlaan M., Gray J. W. Double labeling with iodo- and bromodeoxyuridine for cell kinetics studies. J Histochem Cytochem. 1989 Jul;37(7):1007–1011. doi: 10.1177/37.7.2659659. [DOI] [PubMed] [Google Scholar]
  29. Shrieve D. C., Begg A. C. Cell cycle kinetics of aerated, hypoxic and re-aerated cells in vitro using flow cytometric determination of cellular DNA and incorporated bromodeoxyuridine. Cell Tissue Kinet. 1985 Nov;18(6):641–651. doi: 10.1111/j.1365-2184.1985.tb00707.x. [DOI] [PubMed] [Google Scholar]
  30. Silvestrini R., Molinari R., Costa A., Volterrani F., Gardani G. Short-term variation in labeling index as a predictor of radiotherapy response in human oral cavity carcinoma. Int J Radiat Oncol Biol Phys. 1984 Jul;10(7):965–970. doi: 10.1016/0360-3016(84)90164-0. [DOI] [PubMed] [Google Scholar]
  31. Tubiana M., Pejovic M. H., Koscielny S., Chavaudra N., Malaise E. Growth rate, kinetics of tumor cell proliferation and long-term outcome in human breast cancer. Int J Cancer. 1989 Jul 15;44(1):17–22. doi: 10.1002/ijc.2910440104. [DOI] [PubMed] [Google Scholar]
  32. White R. A., Terry N. H., Baggerly K. A., Meistrich M. L. Measuring cell proliferation by relative movement. I. Introduction and in vitro studies. Cell Prolif. 1991 May;24(3):257–270. doi: 10.1111/j.1365-2184.1991.tb01155.x. [DOI] [PubMed] [Google Scholar]
  33. Wilson G. D., Martindale C. A., Soranson J. A., Carl U. M., McNally N. J. Proliferative changes in two murine tumours in response to single or fractionated doses of X-rays. Cell Prolif. 1992 Sep;25(5):415–430. doi: 10.1111/j.1365-2184.1992.tb01451.x. [DOI] [PubMed] [Google Scholar]
  34. Wilson G. D., McNally N. J., Dische S., Saunders M. I., Des Rochers C., Lewis A. A., Bennett M. H. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer. 1988 Oct;58(4):423–431. doi: 10.1038/bjc.1988.234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wilson G. D., McNally N. J., Dunphy E., Kärcher H., Pfragner R. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry. 1985 Nov;6(6):641–647. doi: 10.1002/cyto.990060621. [DOI] [PubMed] [Google Scholar]
  36. deFazio A., Leary J. A., Hedley D. W., Tattersall M. H. Immunohistochemical detection of proliferating cells in vivo. J Histochem Cytochem. 1987 May;35(5):571–577. doi: 10.1177/35.5.3549891. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES